Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Nov 12:5:23.
doi: 10.1186/1746-160X-5-23.

In vitro proliferation of human osteogenic cells in presence of different commercial bone substitute materials combined with enamel matrix derivatives

Affiliations

In vitro proliferation of human osteogenic cells in presence of different commercial bone substitute materials combined with enamel matrix derivatives

Christoph Reichert et al. Head Face Med. .

Abstract

Background: Cellular reactions to alloplastic bone substitute materials (BSM) are a subject of interest in basic research. In regenerative dentistry, these bone grafting materials are routinely combined with enamel matrix derivatives (EMD) in order to additionally enhance tissue regeneration.

Materials and methods: The aim of this study was to evaluate the proliferative activity of human osteogenic cells after incubation over a period of seven days with commercial BSM of various origin and chemical composition. Special focus was placed on the potential additional benefit of EMD on cellular proliferation.

Results: Except for PerioGlas, osteogenic cell proliferation was significantly promoted by the investigated BSM. The application of EMD alone also resulted in significantly increased cellular proliferation. However, a combination of BSM and EMD resulted in only a moderate additional enhancement of osteogenic cell proliferation.

Conclusion: The application of most BSM, as well as the exclusive application of EMD demonstrated a positive impact on the proliferation of human osteogenic cells in vitro. In order to increase the benefit from substrate combination (BSM + EMD), further studies on the interactions between BSM and EMD are needed.

PubMed Disclaimer

Figures

Figure 1
Figure 1
figure illustrating Bonferroni's t-test for AB reduction of osteogenic cells cultivated on the various BSM compared to the control after 7 d.
Figure 2
Figure 2
figure illustrating Bonferroni's t-test for AB reduction of osteogenic cells cultivated on the various BSM compared to the untreated control or EMD after 7 d.
Figure 3
Figure 3
figure illustrating Comparison of BSM without EMD to BSM + EMD on osteogenic cell proliferation after 24 h and 7 d using the t-test.
Figure 4
Figure 4
figure illustrating Comparison of BSM without EMD to BSM + EMD on osteogenic cell proliferation after 24 h and 7 d using the t-test.

Similar articles

Cited by

References

    1. Eppley BL, Pietrzak WS, Blanton MW. Allograft and alloplastic bone substitutes: a review of science and technology for the craniomaxillofacial surgeon. J Craniofac Surg. 2005;16(6):981–9. doi: 10.1097/01.scs.0000179662.38172.dd. - DOI - PubMed
    1. Esposito M. The efficiancy of various bone augmentation procedures for dental implants: a Cochrane systematic review of randomized controlled clinical trials. Int J Oral Maxillofac Implants. 2006;21(5):696–710. - PubMed
    1. Orsini M. Long-term clinical results on the use of bone-replacement grafts in the treatment of intrabony periodontal defects. Comparison of the use of autogenous bone graft plus calcium sulfate to autogenous bone graft covered with a bioabsorbable membrane. J Peridontol. 2008;79(9):1630–1637. doi: 10.1902/jop.2008.070282. - DOI - PubMed
    1. Sculean A. Healing of human intrabony defects following regenerative periodontal therapy with a bovine-derived xenograft and guided tissue regeneration. Clin Oral Investig. 2004;8(2):70–74. doi: 10.1007/s00784-004-0254-7. - DOI - PubMed
    1. Sculean A. Clinical and histologic evaluation of an enamel matrix derivative combined with a biphasic calcium phosphate for the treatment of human intrabony periodontal defects. J Peridontol. 2008;79(10):1991–1999. doi: 10.1902/jop.2008.080009. - DOI - PubMed

Publication types

LinkOut - more resources